New Users of Sodium-Glucose Cotransporter 2 Inhibitors Are at Low Risk of Prostate Cancer: A Nationwide Cohort Study.

Sodium-Glucose Cotransporter 2 抑制劑新使用者罹患前列腺癌風險低：全國性世代研究